Página de resultados 12 para o Setor de Atividade: Saúde Ramo de Atividade: Biotecnologia Mercado de Ações - Cotações e Preços
Lista de todas as ações e títulos com preços, capitalizações de mercado, P/E (índice preço/lucro) e EPS (lucro por ação)
Todos os países
- {{country.name}}
- Todos os países
- Estados Unidos (1011)
- Austrália (58)
- Áustria (16)
- Bélgica (7)
- Brasil (16)
- Canadá (83)
- China (94)
- Dinamarca (6)
- Finlândia (4)
- França (41)
- Alemanha (737)
- Hong Kong (46)
- Índia (19)
- Irlanda (1)
- Israel (19)
- Itália (4)
- Japão (37)
- México (28)
- Países Baixos (3)
- Nova Zelândia (1)
- Noruega (14)
- Polônia (9)
- Rússia (2)
- Coreia do Sul (10)
- Espanha (4)
- Suécia (70)
- Suíça (11)
- Taiwan (67)
- Tailândia (2)
- Turquia (1)
- Reino Unido (69)
Todas as bolsas de valores
- {{item.name}}
- Todas as bolsas de valores
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (278)
- NasdaqGM (142)
- NasdaqGS (239)
- NSE (10)
- NYSE (10)
- NYSE American (20)
- NZSE (1)
- Oslo (14)
- Other OTC (322)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (38)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Saúde (2608)
- {{item.name}}
- Todos os setores
- Saúde (2608)
Biotecnologia (2608)
- {{item.name}}
- Todas as indústrias
- Biotecnologia (2608)
- Fabricantes de Medicamentos-Gerais (279)
- Fabricantes de Medicamentos-Especializados e Genéricos (1702)
- Planos de Assistência Médica (57)
- Instalações de Assistência Médica (554)
- Drogarias (155)
- Serviços de Informações de Saúde (420)
- Dispositivos Médicos (913)
- Instrumentos e Suprimentos Médicos (502)
- Diagnóstico e Pesquisa (427)
- Distribuição de Produtos Médicos (138)
| Nome Nome | Preço Preço |
24h% 7d Gráfico 24h% & 7d |
M.Cap Capitalização de Mercado | VOL Volume | Baixa 24h | Alta 24h | Capitalização de Mercado | Índice P/L | LPA |
|---|
| Nome Nome | Preço Preço |
24h% 7d Gráfico 24h% & 7d |
M.Cap Capitalização de Mercado | VOL Volume | Baixa 24h | Alta 24h | Capitalização de Mercado | Índice P/L | LPA | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Novo Nordisk A/S NOVA.F | $136.5 149.21 USD |
0
|
$613.75B 670.91B USD | $1.02K 1.11K USD | $136 148.67 USD | $140 153.04 USD | $613.75B 670.91B USD | 50.93 | $2.68 2.93 USD | |
| Novo Nordisk A/S NVON.MX | $2,653.66 157.13 USD |
-0.5
|
$6.12T 362.36B USD | $58 3.43 USD | $2,653.66 157.13 USD | $2,653.66 157.13 USD | $6.12T 362.36B USD | 42.73 | $62.09 3.68 USD | |
| Vertex Pharmaceuticals Incorporated VRTX34.SA | $642.16 130.16 USD |
0
|
$662.84B 134.35B USD | $0 0 USD | $642.16 130.16 USD | $642.16 130.16 USD | $662.84B 134.35B USD | 30.96 | $20.74 4.2 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $98.7 20 USD |
+2.28
|
$652.52B 132.25B USD | $2 0.41 USD | $98.7 20 USD | $98.7 20 USD | $652.52B 132.25B USD | 32.46 | $3.04 0.62 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.MX | $8,511 503.96 USD |
0
|
$2.2T 130.05B USD | $5 0.3 USD | $8,511 503.96 USD | $8,511 503.96 USD | $2.2T 130.05B USD | 30.76 | $276.61 16.38 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $449 490.82 USD |
+1.05
|
$115.87B 126.66B USD | $26.29K 28.74K USD | $440.35 481.36 USD | $450 491.91 USD | $115.87B 126.66B USD | 31.28 | $14.35 15.69 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $19,404.73 1149 USD |
0
|
$2.12T 125.52B USD | $42 2.49 USD | $19,404.73 1149 USD | $19,404.73 1149 USD | $2.12T 125.52B USD | 31.94 | $607.37 35.96 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $443.2 484.48 USD |
-0.21
|
$114.37B 125.02B USD | $0 0 USD | $443.2 484.48 USD | $443.2 484.48 USD | $114.37B 125.02B USD | 30.71 | $14.43 15.77 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $442.8 484.04 USD |
+0.33
|
$114.33B 124.98B USD | $65 71.05 USD | $441.8 482.95 USD | $444.4 485.79 USD | $114.33B 124.98B USD | 30.87 | $14.34 15.68 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $1,003.5 1096.96 USD |
-0.1
|
$109.91B 120.15B USD | $0 0 USD | $1,003.5 1096.96 USD | $1,003.5 1096.96 USD | $109.91B 120.15B USD | 31.61 | $31.74 34.7 USD | |
| CSL Limited CSJ.F | $182.36 199.34 USD |
+0.65
|
$88.58B 96.82B USD | $15 16.4 USD | $182.36 199.34 USD | $182.36 199.34 USD | $88.58B 96.82B USD | 38.39 | $4.75 5.19 USD | |
| CSL Limited CSJA.F | $90.5 98.93 USD |
+0.56
|
$88.49B 96.73B USD | $36 39.35 USD | $90.5 98.93 USD | $90.5 98.93 USD | $88.49B 96.73B USD | 38.18 | $2.37 2.59 USD | |
| CSL CMXHF | $192 — |
0
|
$94.55B — | $80 — | $192 — | $192 — | $94.55B — | 37.79 | $5.08 — | |
| Moderna, Inc. M1RN34.SA | $36 7.3 USD |
-5.71
|
$275.93B 55.93B USD | $15.59K 3.16K USD | $35 7.09 USD | $37.92 7.69 USD | $275.93B 55.93B USD | 0 | -$4.21 -0.8 USD | |
| Moderna, Inc. 0QF.MU | $128.08 140.01 USD |
+0.63
|
$49.45B 54.05B USD | $1 1.09 USD | $128.08 140.01 USD | $128.08 140.01 USD | $49.45B 54.05B USD | 0 | -$14.53 -15.8 USD | |
| Moderna, Inc. MRNA.MX | $2,375 140.63 USD |
-6.76
|
$910.2B 53.89B USD | $27 1.6 USD | $2,375 140.63 USD | $2,375 140.63 USD | $910.2B 53.89B USD | 0 | -$280.1 -16.5 USD | |
| Moderna, Inc. 0QF.F | $121.12 132.4 USD |
-5.29
|
$46.54B 50.87B USD | $409 447.09 USD | $121.12 132.4 USD | $129.08 141.1 USD | $46.54B 50.87B USD | 0 | -$14.53 -15.8 USD | |
| Moderna, Inc. MRNA.VI | $121.14 132.42 USD |
-5.62
|
$46.43B 50.75B USD | $103 112.59 USD | $120.3 131.5 USD | $129.1 141.12 USD | $46.43B 50.75B USD | 0 | -$14.58 -15.9 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $65.56 13.29 USD |
+31.94
|
$216.12B 43.8B USD | $1 0.2 USD | $65.56 13.29 USD | $65.56 13.29 USD | $216.12B 43.8B USD | 0 | -$0.71 -0.1 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $729,000 550.28 USD |
-1.22
|
$51.89T 39.17B USD | $64.02K 48.33 USD | $728,000 549.52 USD | $739,000 557.82 USD | $51.89T 39.17B USD | 0 | $0 0 USD | |
| argenx SE ARGX.VI | $425.6 465.24 USD |
+20.36
|
$29.01B 31.71B USD | $0 0 USD | $425.6 465.24 USD | $425.6 465.24 USD | $29.01B 31.71B USD | 0 | -$5.3 -5.7 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $222.7 243.44 USD |
+0.77
|
$28.53B 31.18B USD | $278 303.89 USD | $222.7 243.44 USD | $222.7 243.44 USD | $28.53B 31.18B USD | 0 | -$2.45 -2.6 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $6 6.56 USD | $227.2 248.36 USD | $227.2 248.36 USD | $27.27B 29.81B USD | 0 | -$7.12 -7.7 USD | |
| argenx SE A1RG34.SA | $86.11 17.45 USD |
0
|
$146.17B 29.63B USD | $0 0 USD | $86.11 17.45 USD | $86.11 17.45 USD | $146.17B 29.63B USD | 0 | -$30.63 -6.2 USD | |
| UCB SA UCB.VI | $136.8 149.54 USD |
-0.51
|
$26.22B 28.66B USD | $0 0 USD | $136.8 149.54 USD | $136.8 149.54 USD | $26.22B 28.66B USD | 77.72 | $1.76 1.92 USD | |
| UCB SA UNC.F | $136.5 149.21 USD |
-1.34
|
$26B 28.42B USD | $349 381.5 USD | $136.45 149.16 USD | $136.5 149.21 USD | $26B 28.42B USD | 77.55 | $1.76 1.92 USD | |
| UCB SA UNC0.F | $67.5 73.79 USD |
-1.46
|
$25.97B 28.38B USD | $4 4.37 USD | $68.5 74.88 USD | $68.5 74.88 USD | $25.97B 28.38B USD | 76.70 | $0.88 0.96 USD | |
| UCB SA UCBJF | $132.5 — |
0
|
$28.27B — | $623 — | $132 — | $132.5 — | $28.27B — | 70.85 | $1.87 — | |
| Celltrion, Inc. 068270.KS | $176,800 133.46 USD |
-0.9
|
$36.69T 27.7B USD | $410.5K 309.86 USD | $176,600 133.3 USD | $178,300 134.59 USD | $36.69T 27.7B USD | 0 | $0 0 USD | |
| argenx SE 1AE.F | $422.3 461.63 USD |
+3.1
|
$25.1B 27.44B USD | $14 15.3 USD | $422.3 461.63 USD | $422.3 461.63 USD | $25.1B 27.44B USD | 0 | -$5.28 -5.7 USD | |
| argenx SE 1AEA.F | $422 461.3 USD |
+0.48
|
$25.08B 27.42B USD | $10 10.93 USD | $416 454.74 USD | $422 461.3 USD | $25.08B 27.42B USD | 0 | -$5.29 -5.7 USD | |
| argenx SE ARGNF | $373.5 — |
0
|
$25.76B — | $1K — | $373.5 — | $373.5 — | $25.76B — | 0 | -$5.68 — | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $77 84.17 USD | $331 361.83 USD | $331 361.83 USD | $21.66B 23.68B USD | 68.12 | $4.86 5.31 USD | |
| BioNTech SE 0A3M.IL | $83.57 — |
-2.11
|
$22.99B — | $499 — | $83.01 — | $84.19 — | $22.99B — | 4.64 | $18 — | |
| BioNTech SE B1NT34.SA | $28.75 5.83 USD |
0
|
$110.86B 22.47B USD | $3 0.61 USD | $28.75 5.83 USD | $28.75 5.83 USD | $110.86B 22.47B USD | 169.11 | $0.17 0.03 USD | |
| Genmab A/S 0MGB.IL | $1,787.5 262.09 USD |
-0.36
|
$143.14B 20.99B USD | $10.61K 1.56K USD | $1,779 260.84 USD | $1,815 266.12 USD | $143.14B 20.99B USD | 25.25 | $70.77 10.38 USD | |
| BioNTech SE BNTX.VI | $79.15 86.52 USD |
-0.81
|
$19.07B 20.85B USD | $0 0 USD | $79.15 86.52 USD | $79.15 86.52 USD | $19.07B 20.85B USD | 168.40 | $0.47 0.51 USD | |
| BioNTech SE 22UA.F | $78.05 85.32 USD |
-1.39
|
$18.81B 20.56B USD | $540 590.29 USD | $78.05 85.32 USD | $79.2 86.58 USD | $18.81B 20.56B USD | 166.06 | $0.47 0.51 USD | |
| BeiGene, Ltd. B1GN34.SA | $33.97 6.89 USD |
0
|
$92.25B 18.7B USD | $0 0 USD | $33.97 6.89 USD | $33.97 6.89 USD | $92.25B 18.7B USD | 0 | -$3.13 -0.6 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $231 46.82 USD |
0
|
$87.72B 17.78B USD | $0 0 USD | $231 46.82 USD | $231 46.82 USD | $87.72B 17.78B USD | 80.76 | $2.86 0.58 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,565 92.67 USD |
0
|
$297.16B 17.6B USD | $0 0 USD | $1,565 92.67 USD | $1,565 92.67 USD | $297.16B 17.6B USD | 81.98 | $19.09 1.13 USD | |
| BeiGene, Ltd. 49B.F | $10.7 11.7 USD |
0
|
$15.94B 17.43B USD | $12 13.12 USD | $10.7 11.7 USD | $10.7 11.7 USD | $15.94B 17.43B USD | 0 | -$0.54 -0.5 USD | |
| Genmab A/S GMAB.VI | $241.2 263.66 USD |
+0.46
|
$15.41B 16.85B USD | $0 0 USD | $241.2 263.66 USD | $241.2 263.66 USD | $15.41B 16.85B USD | 21.69 | $11.12 12.16 USD | |
| Genmab A/S GNMSF | $257.98 — |
0
|
$16.79B — | $1 — | $257.98 — | $257.98 — | $16.79B — | 21.69 | $11.89 — | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $23 25.14 USD | $80.76 88.28 USD | $81.08 88.63 USD | $15.26B 16.68B USD | 115.74 | $0.7 0.77 USD | |
| Sarepta Therapeutics, Inc. S1RP34.SA | $43.4 8.8 USD |
+0.7
|
$82.05B 16.63B USD | $45 9.12 USD | $42.5 8.61 USD | $43.4 8.8 USD | $82.05B 16.63B USD | 361.66 | $0.12 0.02 USD | |
| BeiGene, Ltd. 49BA.F | $139 151.95 USD |
-4.79
|
$15.18B 16.59B USD | $26 28.42 USD | $139 151.95 USD | $139 151.95 USD | $15.18B 16.59B USD | 0 | -$7.02 -7.6 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $79.56 86.97 USD |
-0.92
|
$15.11B 16.51B USD | $0 0 USD | $79.56 86.97 USD | $79.56 86.97 USD | $15.11B 16.51B USD | 79.56 | $1 1.09 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $79.26 86.64 USD |
+0.15
|
$15.06B 16.46B USD | $205 224.09 USD | $79.26 86.64 USD | $79.26 86.64 USD | $15.06B 16.46B USD | 80.06 | $0.99 1.08 USD | |
| Royalty Pharma plc RPD.MU | $25.11 27.45 USD |
0
|
$14.98B 16.37B USD | $100 109.31 USD | $25.11 27.45 USD | $25.11 27.45 USD | $14.98B 16.37B USD | 15.12 | $1.66 1.81 USD | |
| Royalty Pharma plc RPD.F | $24.89 27.21 USD |
-0.64
|
$14.88B 16.27B USD | $200 218.63 USD | $24.89 27.21 USD | $24.89 27.21 USD | $14.88B 16.27B USD | 14.99 | $1.66 1.81 USD | |
| Sarepta Therapeutics, Inc. AB3A.F | $145.55 159.11 USD |
-1.92
|
$13.76B 15.04B USD | $12 13.12 USD | $145.55 159.11 USD | $145.55 159.11 USD | $13.76B 15.04B USD | 363.87 | $0.4 0.44 USD | |
| United Therapeutics Corporation UTH.F | $302 330.13 USD |
+2.23
|
$13.48B 14.74B USD | $15 16.4 USD | $301 329.03 USD | $302 330.13 USD | $13.48B 14.74B USD | 15.35 | $19.67 21.5 USD | |
| Incyte Corporation I1NC34.SA | $167.5 33.95 USD |
0
|
$67.03B 13.59B USD | $0 0 USD | $167.5 33.95 USD | $167.5 33.95 USD | $67.03B 13.59B USD | 18.84 | $8.89 1.8 USD | |
| Incyte Corporation INCY.MX | $1,096.52 64.93 USD |
0
|
$223.26B 13.22B USD | $0 0 USD | $1,096.52 64.93 USD | $1,096.52 64.93 USD | $223.26B 13.22B USD | 18.48 | $59.32 3.51 USD | |
| Bio-Techne Corporation T1CH34.SA | $13.38 2.71 USD |
0
|
$63.25B 12.82B USD | $0 0 USD | $13.38 2.71 USD | $13.38 2.71 USD | $63.25B 12.82B USD | 60.81 | $0.22 0.04 USD | |
| Incyte Corporation ICY.F | $58.84 64.32 USD |
-0.68
|
$11.59B 12.67B USD | $290 317.01 USD | $58.84 64.32 USD | $58.84 64.32 USD | $11.59B 12.67B USD | 19.16 | $3.07 3.36 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| Bio-Techne Corporation TECH.MX | $1,310.32 77.59 USD |
-2.54
|
$206.49B 12.23B USD | $0 0 USD | $0 0 USD | $0 0 USD | $206.49B 12.23B USD | 51.58 | $25.4 1.5 USD | |
| Insmed Incorporated IM8N.F | $65 71.05 USD |
+2.36
|
$10.84B 11.85B USD | $74 80.89 USD | $65 71.05 USD | $65 71.05 USD | $10.84B 11.85B USD | 0 | -$4.87 -5.3 USD | |
| Bio-Techne Corporation TE1.F | $68 74.33 USD |
0
|
$10.73B 11.73B USD | $2 2.19 USD | $68 74.33 USD | $68 74.33 USD | $10.73B 11.73B USD | 58.62 | $1.16 1.27 USD | |
| Insmed Incorporated IM8N.SG | $65 71.05 USD |
0
|
$10.6B 11.59B USD | $0 0 USD | $63.5 69.41 USD | $65 71.05 USD | $10.6B 11.59B USD | 0 | -$4.88 -5.3 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Ascendis Pharma A/S A1SN34.SA | $45.1 9.14 USD |
0
|
$41.82B 8.48B USD | $0 0 USD | $45.1 9.14 USD | $45.1 9.14 USD | $41.82B 8.48B USD | 0 | -$51.32 -10.4 USD | |
| Innovent Biologics, Inc. 6IB.F | $4.52 4.94 USD |
+4.15
|
$7.65B 8.36B USD | $130 142.11 USD | $4.52 4.94 USD | $4.68 5.12 USD | $7.65B 8.36B USD | 0 | -$0.08 -0.08 USD | |
| Vaxcyte, Inc. 5VA.MU | $70 76.52 USD |
-0.71
|
$7.62B 8.32B USD | $10 10.93 USD | $70 76.52 USD | $70 76.52 USD | $7.62B 8.32B USD | 0 | -$4 -4.3 USD | |
| Ascendis Pharma A/S A71.F | $126 137.74 USD |
+5
|
$7.59B 8.3B USD | $1K 1.09K USD | $120 131.18 USD | $120 131.18 USD | $7.59B 8.3B USD | 0 | -$8.87 -9.6 USD | |
| Vaxcyte, Inc. 5VA.F | $69.5 75.97 USD |
-1.42
|
$7.56B 8.27B USD | $4 4.37 USD | $69.5 75.97 USD | $69.5 75.97 USD | $7.56B 8.27B USD | 0 | -$4 -4.3 USD | |
| Roivant Sciences Ltd. 87S.F | $9.64 10.54 USD |
-0.66
|
$7.41B 8.1B USD | $500 546.57 USD | $9.64 10.54 USD | $9.67 10.57 USD | $7.41B 8.1B USD | 1.97 | $4.87 5.32 USD | |
| Zealand Pharma A/S ZLDPF | $127.88 — |
+1.13
|
$8.08B — | $40 — | $127.88 — | $127.88 — | $8.08B — | 0 | -$1.78 — | |
| Innovent Biologics IVBXF | $4.92 — |
0
|
$7.98B — | $1K — | $4.92 — | $4.92 — | $7.98B — | 0 | -$0.09 — | |
| Legend Biotech Corporation 9LB.F | $39.8 43.51 USD |
-1.49
|
$7.28B 7.96B USD | $50 54.66 USD | $39.8 43.51 USD | $40.4 44.16 USD | $7.28B 7.96B USD | 0 | -$2.4 -2.6 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $900 53.29 USD |
0
|
$131.37B 7.78B USD | $0 0 USD | $900 53.29 USD | $900 53.29 USD | $131.37B 7.78B USD | 0 | -$42.65 -2.5 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $92 100.57 USD | $21.09 23.05 USD | $21.09 23.05 USD | $6.79B 7.42B USD | 23.17 | $0.91 0.99 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $44.57 48.72 USD |
+5.54
|
$6.74B 7.37B USD | $65 71.05 USD | $44.57 48.72 USD | $44.57 48.72 USD | $6.74B 7.37B USD | 0 | -$2.49 -2.7 USD | |
| Blueprint Medicines Corporation 2L9.F | $100.85 110.24 USD |
+3.03
|
$6.4B 7B USD | $50 54.66 USD | $98.16 107.3 USD | $100.85 110.24 USD | $6.4B 7B USD | 0 | -$4.49 -4.9 USD | |
| Sino Biopharmaceutical Limited SBMFF | $0.3699 — |
+16.05
|
$6.92B — | $1.89K — | $0.3699 — | $0.3699 — | $6.92B — | 36.54 | $0.01 — | |
| Jazz Pharmaceuticals plc J7Z.F | $99.56 108.83 USD |
-1.67
|
$6.28B 6.86B USD | $41 44.82 USD | $99.56 108.83 USD | $101.35 110.79 USD | $6.28B 6.86B USD | 22.12 | $4.5 4.92 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $48.8 53.34 USD |
+0.93
|
$6.27B 6.85B USD | $5 5.47 USD | $48.77 53.31 USD | $48.8 53.34 USD | $6.27B 6.85B USD | 21.78 | $2.24 2.45 USD | |
| Sino Biopharmaceutical SBHMY | $7.2 — |
-2.83
|
$6.84B — | $1.25K — | $7.2 — | $7.2 — | $6.84B — | 25.71 | $0.28 — | |
| Exelixis, Inc. EX9.F | $20.6 22.52 USD |
+0.05
|
$6.05B 6.61B USD | $500 546.57 USD | $20.6 22.52 USD | $20.6 22.52 USD | $6.05B 6.61B USD | 33.77 | $0.61 0.67 USD | |
| Revolution Medicines, Inc. 42Z.F | $36.2 39.57 USD |
+1.12
|
$6.03B 6.59B USD | $25 27.33 USD | $36.2 39.57 USD | $36.2 39.57 USD | $6.03B 6.59B USD | 0 | -$3.58 -3.9 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $2.78 3.04 USD |
+2.21
|
$6.02B 6.58B USD | $1.05K 1.14K USD | $2.72 2.97 USD | $2.72 2.97 USD | $6.02B 6.58B USD | 13.90 | $0.2 0.22 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $1.43 1.56 USD |
+2.12
|
$6.01B 6.57B USD | $208 227.37 USD | $1.43 1.56 USD | $1.43 1.56 USD | $6.01B 6.57B USD | 14.25 | $0.1 0.11 USD | |
| Cytokinetics, Incorporated KK3A.F | $48.8 53.34 USD |
-0.41
|
$5.75B 6.28B USD | $80 87.45 USD | $48.8 53.34 USD | $48.8 53.34 USD | $5.75B 6.28B USD | 0 | -$5.03 -5.4 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $259.1 283.23 USD |
-0.31
|
$5.54B 6.06B USD | $100 109.31 USD | $255.8 279.62 USD | $259.1 283.23 USD | $5.54B 6.06B USD | 0 | -$21.57 -23.5 USD | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| Krystal Biotech, Inc. 4KB.F | $167.9 183.54 USD |
+1.63
|
$4.89B 5.34B USD | $17 18.58 USD | $167.9 183.54 USD | $167.9 183.54 USD | $4.89B 5.34B USD | 82.70 | $2.03 2.22 USD | |
| Viking Therapeutics, Inc. 1VT.F | $44.13 48.24 USD |
-2.65
|
$4.87B 5.32B USD | $1.2K 1.31K USD | $42.52 46.48 USD | $44.13 48.24 USD | $4.87B 5.32B USD | 0 | -$0.86 -0.9 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| ALK-Abelló A/S AKBLF | $21.17 — |
0
|
$5.27B — | $1K — | $21.17 — | $21.17 — | $5.27B — | 57.21 | $0.37 — | |
| Krystal Biotech, Inc. 4KB.SG | $164.7 180.04 USD |
-0.3
|
$4.79B 5.24B USD | $0 0 USD | $164.7 180.04 USD | $168.1 183.76 USD | $4.79B 5.24B USD | 81.13 | $2.03 2.22 USD | |
| ALK-Abelló A/S 4AJ0.F | $21.12 23.09 USD |
+1.44
|
$4.77B 5.22B USD | $15 16.4 USD | $21.12 23.09 USD | $21.2 23.17 USD | $4.77B 5.22B USD | 60.34 | $0.35 0.38 USD | |
|
Sem ações favoritas
Você ainda não possui ações favoritas. Por favor, adicione-as aos favoritos para vê-las aqui. |
||||||||||